WuXi Biologics Recognized as Industry and Regional ESG Top-Rated Company by Morningstar Sustainalytics for Fifth Consecutive Year
Ranked among the top 1% of companies assessed in the pharmaceutical industry Recognized as a leader in Green CRDMO, driving innovation for a healthier future Committed to creating long-term value for all stakeholders SHANGHAI, Feb. 10, 2025...
CNN's The Journey Matters explores the diverse cultures and communities of picturesque Philippines
HONG KONG, Feb. 10, 2025 /PRNewswire/ -- Join The Journey Matters as CNN showcases creative ways to discover the stunning beauty of the Philippines. With nearly six million international visitors arriving in the Philippines in 2024, tourists are...
ISLE 2025 to Open on March 7: Global Innovation & Production Hub of LED Display & Integrated System
SHENZHEN, China, Feb. 10, 2025 /PRNewswire/ -- ISLE 2025, Asia's biggest exhibition of Smart Display & Integrated System, will take place at Shenzhen World Exhibition & Convention Center (SHENZHEN WORLD) from March 7‐9, 2025. Located in...
Global Times: From regional specialty to global delicacy, roujiamo bridges cultures, makes Chinese cuisine international
BEIJING, Feb. 10, 2025 /PRNewswire/ -- In September 2024, a giant billboard featuring the eye-catching slogan "Not China's hamburger, but the world's roujiamo" lit up Times Square in New York. Roujiamo - a soft flatbread sliced open, filled with...
BioRay's ROR1-Targeting Dual-Epitope ADC Drug BR111 Receives Formal Clinical Trial Approval from NMPA
SHANGHAI, Feb. 10, 2025 /PRNewswire/ -- On December 19, 2024, BioRay Pharmaceutical Co., Ltd. ("BioRay") announced that the National Medical Products Administration (NMPA) has accepted the clinical trial application for its self-developed Class 1...
Meeting Australia's Growing Demand for Sustainable Tissue Products: APP Group and Sorbent Paper Lead the Charge
JAKARTA, Indonesia, Feb. 10, 2025 /PRNewswire/ -- Consumer demands in Australia have shifted over the past few years. Based on the survey conducted by Monash University, it stated that almost half of Australian shoppers (46%) believe that...
Address Advisors Setting Benchmarks for GCC's Real Estate Solutions in India
SINGAPORE and BENGALURU, India, Feb. 10, 2025 /PRNewswire/ -- Address Advisors, a leading real estate consulting firm in India, is offering the GCCs entering the Indian market comprehensive support. Through their occupier service solutions, the firm...
Caliway Announces CBL-514 Second Phase 2b Study Results (CBL-0205) Met Endpoints
CBL-514, the world's first investigational drug for large-area localized fat reduction, has demonstrated significant efficacy in its second and the last Phase 2b study (CBL-0205) before Phase 3. 54.2% of participants in the CBL-514 group achieved at...